Trending Now
Immix Biopharma Inc. (NASDAQ: IMMX) Release Study Showing That IMX-110 Can...
Immix Biopharma Inc. (NASDAQ: IMMX) has announced study findings demonstrating that its flagship candidate IMX-110 created a 50% response rate in first-line-treatment-resistant cancer- soft...
Aclaris Therapeutics (ACRS): Strategic Alliance with Biosion Ignites 53% Stock Surge
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) experienced a remarkable 53.17% spike in its stock price, closing at $3.14 on November 18, 2024, following...
Sintx Technologies, Inc. (SINT): A Bold Move with Strategic Stock Repurchase...
Sintx Technologies, Inc. (NASDAQ: SINT), a leader in advanced ceramics for medical and technical applications, made headlines on November 18, 2024, with...
Popular News
Agile Therapeutics (NASDAQ:AGRX) goes parabolic on positive sentiment and continued run
Agile Therapeutics (NASDAQ:AGRX) is expecting a FDA approval for its contraceptive patch, Twirla. However, right now the technical chart looks impressive. Agile...
MAKE IT MODERN
LATEST REVIEWS
Moderna Inc‘s (NASDAQ: MRNA) Chair Noubar Afeyan Explains How They Leveraged...
Moderna (NASDAQ: MRNA) Char Noubar Afeyan has explained how his combination of science with business acumen led to the creation of a vaccine to...
MAKE IT MODERN
PERFORMANCE TRAINING
Nektar Therapeutics (NASDAQ:NKTR) Doses First Patient In NKTR-255 Study In HNSCC and CRC Patients
Nektar Therapeutics (NASDAQ:NKTR) has announced the dosing of the first patients in the Phase 1/2 NKTR-255 trial in refractory or relapsed head...
Aerpio Pharmaceuticals Inc. (NASDAQ:ARPO) and Quantum Leap Reports the Dosing of the First Patient...
The collaboration between Aerpio Pharmaceuticals Inc (NASDAQ:ARPO) and Quantum Leap Healthcare has resulted in dosing the first patient with razuprotafib in the I-SPY COVID...
Genmab’s (NASDAQ:GMAB) Licensing Partner, Jansen Biotech Submits sBLA For DARZALEX FASPRO™ In Light-Chain Amyloidosis
Genmab A/S (NASDAQ:GMAB) has announced that Jansen Biotech Inc., its licensing partners, has submitted a supplemental Biologics Licence Application to the FDA for approval...
Evofem Biosciences Inc (NASDAQ:EVFM) Inks A Pact With NCODA To Help Women With Cancer...
Evofem Biosciences Inc (NASDAQ:EVFM) signed a collaboration agreement with the National Community Oncology Dispensing Association, Inc (NCODA) to improve the lives of women suffering...
Pfizer Inc. (NYSE: PFE) and BioNTechSE (NASDAQ: BNTX) Submit Data To FDA Supporting Safety...
Pfizer Inc. (NYSE: PFE) and BioNTechSE (NASDAQ: BNTX) have submitted phase one data to the US FDA supporting the evaluation of a booster or...
MAKE IT MODERN
